CryoLife, Inc. (NYSE:CRY) announced its quarterly earnings data on Monday, July 24th. The medical equipment provider reported $0.12 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.10 by $0.02, Bloomberg Earnings reports. The firm had revenue of $47.80 million during the quarter, compared to analysts’ expectations of $47.02 million. CryoLife had a return on equity of 7.41% and a net margin of 6.16%. The company’s quarterly revenue was up 1.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.13 EPS. CryoLife updated its FY17 guidance to $40-0.43 EPS.
Shares of CryoLife (CRY) opened at 19.05 on Friday. CryoLife has a 52 week low of $14.02 and a 52 week high of $20.30. The stock has a market capitalization of $637.15 million, a P/E ratio of 57.73 and a beta of 0.97. The stock has a 50 day moving average price of $19.18 and a 200 day moving average price of $17.98.
In related news, VP Amy Horton sold 9,577 shares of the business’s stock in a transaction that occurred on Tuesday, June 27th. The shares were sold at an average price of $20.00, for a total value of $191,540.00. Following the completion of the transaction, the vice president now directly owns 112,282 shares in the company, valued at approximately $2,245,640. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 6.00% of the stock is currently owned by company insiders.
Large investors have recently made changes to their positions in the stock. Wells Fargo & Company MN raised its stake in shares of CryoLife by 16.5% in the first quarter. Wells Fargo & Company MN now owns 31,042 shares of the medical equipment provider’s stock worth $517,000 after buying an additional 4,399 shares in the last quarter. Essex Investment Management Co. LLC raised its stake in shares of CryoLife by 12.7% in the first quarter. Essex Investment Management Co. LLC now owns 96,643 shares of the medical equipment provider’s stock worth $1,609,000 after buying an additional 10,904 shares in the last quarter. Louisiana State Employees Retirement System raised its stake in shares of CryoLife by 1.9% in the first quarter. Louisiana State Employees Retirement System now owns 11,000 shares of the medical equipment provider’s stock worth $183,000 after buying an additional 200 shares in the last quarter. Macquarie Group Ltd. raised its stake in shares of CryoLife by 2.1% in the fourth quarter. Macquarie Group Ltd. now owns 1,015,375 shares of the medical equipment provider’s stock worth $19,444,000 after buying an additional 20,898 shares in the last quarter. Finally, Teachers Advisors LLC raised its stake in shares of CryoLife by 2.6% in the fourth quarter. Teachers Advisors LLC now owns 51,720 shares of the medical equipment provider’s stock worth $990,000 after buying an additional 1,322 shares in the last quarter. Institutional investors and hedge funds own 69.22% of the company’s stock.
Several brokerages have weighed in on CRY. Zacks Investment Research raised CryoLife from a “sell” rating to a “hold” rating in a report on Monday, August 14th. BidaskClub lowered CryoLife from a “buy” rating to a “hold” rating in a research report on Monday, July 24th. Finally, Northland Securities restated a “buy” rating and set a $23.50 price objective on shares of CryoLife in a research report on Friday, April 28th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the stock. CryoLife has a consensus rating of “Hold” and an average target price of $22.00.
CryoLife Company Profile
CryoLife, Inc (CryoLife) is a medical device manufacturer and processor, and is engaged in the distribution of medical devices and implantable human tissues used in cardiac surgical procedures. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as BioGlue Surgical Adhesive, BioFoam Surgical Matrix, On-X Life Technologies Holdings, Inc valves and surgical products, CardioGenesis cardiac laser therapy product line, PerClot and PhotoFix.
Receive News & Ratings for CryoLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.